Source: Regulatory Toxicology and Pharmacology. Unidade: FCF
Subjects: MUTAGÊNESE, TOXICOLOGIA
ABNT
WAECHTER, Fernanda et al. Retrospective application of ICH M7 to anti-hypertensive drugs in Brazil: risk assessment of potentially mutagenic impurities. Regulatory Toxicology and Pharmacology, v. 151, p. 1-12 art. 105669, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.yrtph.2024.105669. Acesso em: 31 out. 2024.APA
Waechter, F., Oliveira, A. A. F., Shimada, A. L. B., Bernes Junior, E., & Nascimento, E. de S. (2024). Retrospective application of ICH M7 to anti-hypertensive drugs in Brazil: risk assessment of potentially mutagenic impurities. Regulatory Toxicology and Pharmacology, 151, 1-12 art. 105669. doi:10.1016/j.yrtph.2024.105669NLM
Waechter F, Oliveira AAF, Shimada ALB, Bernes Junior E, Nascimento E de S. Retrospective application of ICH M7 to anti-hypertensive drugs in Brazil: risk assessment of potentially mutagenic impurities [Internet]. Regulatory Toxicology and Pharmacology. 2024 ; 151 1-12 art. 105669.[citado 2024 out. 31 ] Available from: https://dx.doi.org/10.1016/j.yrtph.2024.105669Vancouver
Waechter F, Oliveira AAF, Shimada ALB, Bernes Junior E, Nascimento E de S. Retrospective application of ICH M7 to anti-hypertensive drugs in Brazil: risk assessment of potentially mutagenic impurities [Internet]. Regulatory Toxicology and Pharmacology. 2024 ; 151 1-12 art. 105669.[citado 2024 out. 31 ] Available from: https://dx.doi.org/10.1016/j.yrtph.2024.105669